269 related articles for article (PubMed ID: 31333762)
1. Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids - the state of art.
Ribeiro IP; de Melo JB; Carreira IM
Mol Cytogenet; 2019; 12():33. PubMed ID: 31333762
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
[No Abstract] [Full Text] [Related]
4. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumour cells in metastatic head and neck cancers.
Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
[TBL] [Abstract][Full Text] [Related]
6. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
[TBL] [Abstract][Full Text] [Related]
7. Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB; De Carvalho AC; Melendez ME; Lopes Carvalho A
Expert Rev Mol Diagn; 2018 Jan; 18(1):85-112. PubMed ID: 29134827
[TBL] [Abstract][Full Text] [Related]
8. Tumor DNA: an emerging biomarker in head and neck cancer.
Bellairs JA; Hasina R; Agrawal N
Cancer Metastasis Rev; 2017 Sep; 36(3):515-523. PubMed ID: 28801876
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy for lung cancer early detection.
Santarpia M; Liguori A; D'Aveni A; Karachaliou N; Gonzalez-Cao M; Daffinà MG; Lazzari C; Altavilla G; Rosell R
J Thorac Dis; 2018 Apr; 10(Suppl 7):S882-S897. PubMed ID: 29780635
[TBL] [Abstract][Full Text] [Related]
10. The development of a liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Kenny L; Punyadeera C
Oral Oncol; 2016 Oct; 61():8-11. PubMed ID: 27688098
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.
Tinhofer I; Staudte S
Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647
[TBL] [Abstract][Full Text] [Related]
12. A liquid biopsy for head and neck cancers.
Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
[TBL] [Abstract][Full Text] [Related]
13. Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer-A Systematic Review.
Hudečková M; Koucký V; Rottenberg J; Gál B
Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829777
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges.
Kong L; Birkeland AC
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919778
[TBL] [Abstract][Full Text] [Related]
15. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
Lee KD; Lee HS; Jeon CH
Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
[TBL] [Abstract][Full Text] [Related]
16. The role of tumor DNA as a diagnostic tool for head and neck squamous cell carcinoma.
Chan JYK; Zhen G; Agrawal N
Semin Cancer Biol; 2019 Apr; 55():1-7. PubMed ID: 30082187
[TBL] [Abstract][Full Text] [Related]
17. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.
Pynnonen MA; Gillespie MB; Roman B; Rosenfeld RM; Tunkel DE; Bontempo L; Brook I; Chick DA; Colandrea M; Finestone SA; Fowler JC; Griffith CC; Henson Z; Levine C; Mehta V; Salama A; Scharpf J; Shatzkes DR; Stern WB; Youngerman JS; Corrigan MD
Otolaryngol Head Neck Surg; 2017 Sep; 157(2_suppl):S1-S30. PubMed ID: 28891406
[TBL] [Abstract][Full Text] [Related]
18. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives.
Cristaldi M; Mauceri R; Di Fede O; Giuliana G; Campisi G; Panzarella V
Front Physiol; 2019; 10():1476. PubMed ID: 31920689
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.
Affolter A; Lammert A; Kern J; Scherl C; Rotter N
Front Cell Dev Biol; 2021; 9():666515. PubMed ID: 34307351
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of head and neck squamous cell cancer biomarkers.
Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
